Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.
Identifieur interne : 001F81 ( PubMed/Corpus ); précédent : 001F80; suivant : 001F82Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.
Auteurs : A. Timen ; G J J. Van Doornum ; M. Schutten ; M A E. Conyn-Van Spaendonck ; J W M. Van Der Meer ; A D M E. Osterhaus ; J E Van SteenbergenSource :
- Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases [ 1198-743X ] ; 2006.
English descriptors
- KwdEn :
- Antibodies, Viral (blood), Communicable Disease Control (methods), Disease Outbreaks, Female, Humans, Infection Control (methods), Male, Netherlands (epidemiology), Population Surveillance, Public Health (standards), Reference Standards, Resource Allocation, Retrospective Studies, SARS Virus (genetics), SARS Virus (immunology), SARS Virus (isolation & purification), Sensitivity and Specificity, Severe Acute Respiratory Syndrome (diagnosis), Severe Acute Respiratory Syndrome (epidemiology), Severe Acute Respiratory Syndrome (prevention & control), World Health Organization.
- MESH :
- chemical , blood : Antibodies, Viral.
- geographic , epidemiology : Netherlands.
- diagnosis : Severe Acute Respiratory Syndrome.
- epidemiology : Severe Acute Respiratory Syndrome.
- genetics : SARS Virus.
- immunology : SARS Virus.
- isolation & purification : SARS Virus.
- methods : Communicable Disease Control, Infection Control.
- prevention & control : Severe Acute Respiratory Syndrome.
- standards : Public Health.
- Disease Outbreaks, Female, Humans, Male, Population Surveillance, Reference Standards, Resource Allocation, Retrospective Studies, Sensitivity and Specificity, World Health Organization.
Abstract
This study analysed the consequences of deviation from the WHO case definition for the assessment of patients with suspected severe acute respiratory syndrome (SARS) in The Netherlands during 2003. Between 17 March and 7 July 2003, as a result of dilemmas in balancing sensitivity and specificity, five different case definitions were used. The patients referred for SARS assessment were analysed from a public health perspective. None of the patients referred had SARS, based on serological and virological criteria. Nevertheless, all 72 patients required thorough assessment and, depending on the results of the assessment, institution of appropriate prevention and control measures. Changing case definitions caused confusion in classifying cases. A centralised assessment of the reported cases by a team with clinical and public health expertise (epidemiological and geographical risk assessment) is a practical solution for addressing differences in applying case definitions. The burden of managing non-cases is an important issue when allocating public health resources, and should be taken into account during the preparation phase, rather than during an outbreak. This applies not only to SARS, but also to other public health threats, such as pandemic influenza or a bioterrorist episode.
DOI: 10.1111/j.1469-0691.2006.01552.x
PubMed: 17121628
Links to Exploration step
pubmed:17121628Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.</title><author><name sortKey="Timen, A" sort="Timen, A" uniqKey="Timen A" first="A" last="Timen">A. Timen</name><affiliation><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Aura.Timen@rivm.nl</nlm:affiliation></affiliation></author><author><name sortKey="Van Doornum, G J J" sort="Van Doornum, G J J" uniqKey="Van Doornum G" first="G J J" last="Van Doornum">G J J. Van Doornum</name></author><author><name sortKey="Schutten, M" sort="Schutten, M" uniqKey="Schutten M" first="M" last="Schutten">M. Schutten</name></author><author><name sortKey="Conyn Van Spaendonck, M A E" sort="Conyn Van Spaendonck, M A E" uniqKey="Conyn Van Spaendonck M" first="M A E" last="Conyn-Van Spaendonck">M A E. Conyn-Van Spaendonck</name></author><author><name sortKey="Van Der Meer, J W M" sort="Van Der Meer, J W M" uniqKey="Van Der Meer J" first="J W M" last="Van Der Meer">J W M. Van Der Meer</name></author><author><name sortKey="Osterhaus, A D M E" sort="Osterhaus, A D M E" uniqKey="Osterhaus A" first="A D M E" last="Osterhaus">A D M E. Osterhaus</name></author><author><name sortKey="Van Steenbergen, J E" sort="Van Steenbergen, J E" uniqKey="Van Steenbergen J" first="J E" last="Van Steenbergen">J E Van Steenbergen</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2006">2006</date><idno type="RBID">pubmed:17121628</idno><idno type="pmid">17121628</idno><idno type="doi">10.1111/j.1469-0691.2006.01552.x</idno><idno type="wicri:Area/PubMed/Corpus">001F81</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001F81</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.</title><author><name sortKey="Timen, A" sort="Timen, A" uniqKey="Timen A" first="A" last="Timen">A. Timen</name><affiliation><nlm:affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Aura.Timen@rivm.nl</nlm:affiliation></affiliation></author><author><name sortKey="Van Doornum, G J J" sort="Van Doornum, G J J" uniqKey="Van Doornum G" first="G J J" last="Van Doornum">G J J. Van Doornum</name></author><author><name sortKey="Schutten, M" sort="Schutten, M" uniqKey="Schutten M" first="M" last="Schutten">M. Schutten</name></author><author><name sortKey="Conyn Van Spaendonck, M A E" sort="Conyn Van Spaendonck, M A E" uniqKey="Conyn Van Spaendonck M" first="M A E" last="Conyn-Van Spaendonck">M A E. Conyn-Van Spaendonck</name></author><author><name sortKey="Van Der Meer, J W M" sort="Van Der Meer, J W M" uniqKey="Van Der Meer J" first="J W M" last="Van Der Meer">J W M. Van Der Meer</name></author><author><name sortKey="Osterhaus, A D M E" sort="Osterhaus, A D M E" uniqKey="Osterhaus A" first="A D M E" last="Osterhaus">A D M E. Osterhaus</name></author><author><name sortKey="Van Steenbergen, J E" sort="Van Steenbergen, J E" uniqKey="Van Steenbergen J" first="J E" last="Van Steenbergen">J E Van Steenbergen</name></author></analytic><series><title level="j">Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</title><idno type="ISSN">1198-743X</idno><imprint><date when="2006" type="published">2006</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Antibodies, Viral (blood)</term><term>Communicable Disease Control (methods)</term><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Infection Control (methods)</term><term>Male</term><term>Netherlands (epidemiology)</term><term>Population Surveillance</term><term>Public Health (standards)</term><term>Reference Standards</term><term>Resource Allocation</term><term>Retrospective Studies</term><term>SARS Virus (genetics)</term><term>SARS Virus (immunology)</term><term>SARS Virus (isolation & purification)</term><term>Sensitivity and Specificity</term><term>Severe Acute Respiratory Syndrome (diagnosis)</term><term>Severe Acute Respiratory Syndrome (epidemiology)</term><term>Severe Acute Respiratory Syndrome (prevention & control)</term><term>World Health Organization</term></keywords><keywords scheme="MESH" type="chemical" qualifier="blood" xml:lang="en"><term>Antibodies, Viral</term></keywords><keywords scheme="MESH" type="geographic" qualifier="epidemiology" xml:lang="en"><term>Netherlands</term></keywords><keywords scheme="MESH" qualifier="diagnosis" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="immunology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Communicable Disease Control</term><term>Infection Control</term></keywords><keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Severe Acute Respiratory Syndrome</term></keywords><keywords scheme="MESH" qualifier="standards" xml:lang="en"><term>Public Health</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Disease Outbreaks</term><term>Female</term><term>Humans</term><term>Male</term><term>Population Surveillance</term><term>Reference Standards</term><term>Resource Allocation</term><term>Retrospective Studies</term><term>Sensitivity and Specificity</term><term>World Health Organization</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">This study analysed the consequences of deviation from the WHO case definition for the assessment of patients with suspected severe acute respiratory syndrome (SARS) in The Netherlands during 2003. Between 17 March and 7 July 2003, as a result of dilemmas in balancing sensitivity and specificity, five different case definitions were used. The patients referred for SARS assessment were analysed from a public health perspective. None of the patients referred had SARS, based on serological and virological criteria. Nevertheless, all 72 patients required thorough assessment and, depending on the results of the assessment, institution of appropriate prevention and control measures. Changing case definitions caused confusion in classifying cases. A centralised assessment of the reported cases by a team with clinical and public health expertise (epidemiological and geographical risk assessment) is a practical solution for addressing differences in applying case definitions. The burden of managing non-cases is an important issue when allocating public health resources, and should be taken into account during the preparation phase, rather than during an outbreak. This applies not only to SARS, but also to other public health threats, such as pandemic influenza or a bioterrorist episode.</div></front></TEI><pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">17121628</PMID><DateCompleted><Year>2008</Year><Month>08</Month><Day>15</Day></DateCompleted><DateRevised><Year>2020</Year><Month>04</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Print">1198-743X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>12</Issue><PubDate><Year>2006</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases</Title><ISOAbbreviation>Clin. Microbiol. Infect.</ISOAbbreviation></Journal><ArticleTitle>Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.</ArticleTitle><Pagination><MedlinePgn>1214-20</MedlinePgn></Pagination><Abstract><AbstractText>This study analysed the consequences of deviation from the WHO case definition for the assessment of patients with suspected severe acute respiratory syndrome (SARS) in The Netherlands during 2003. Between 17 March and 7 July 2003, as a result of dilemmas in balancing sensitivity and specificity, five different case definitions were used. The patients referred for SARS assessment were analysed from a public health perspective. None of the patients referred had SARS, based on serological and virological criteria. Nevertheless, all 72 patients required thorough assessment and, depending on the results of the assessment, institution of appropriate prevention and control measures. Changing case definitions caused confusion in classifying cases. A centralised assessment of the reported cases by a team with clinical and public health expertise (epidemiological and geographical risk assessment) is a practical solution for addressing differences in applying case definitions. The burden of managing non-cases is an important issue when allocating public health resources, and should be taken into account during the preparation phase, rather than during an outbreak. This applies not only to SARS, but also to other public health threats, such as pandemic influenza or a bioterrorist episode.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Timen</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, The Netherlands. Aura.Timen@rivm.nl</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Doornum</LastName><ForeName>G J J</ForeName><Initials>GJ</Initials></Author><Author ValidYN="Y"><LastName>Schutten</LastName><ForeName>M</ForeName><Initials>M</Initials></Author><Author ValidYN="Y"><LastName>Conyn-van Spaendonck</LastName><ForeName>M A E</ForeName><Initials>MA</Initials></Author><Author ValidYN="Y"><LastName>van der Meer</LastName><ForeName>J W M</ForeName><Initials>JW</Initials></Author><Author ValidYN="Y"><LastName>Osterhaus</LastName><ForeName>A D M E</ForeName><Initials>AD</Initials></Author><Author ValidYN="Y"><LastName>van Steenbergen</LastName><ForeName>J E</ForeName><Initials>JE</Initials></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Clin Microbiol Infect</MedlineTA><NlmUniqueID>9516420</NlmUniqueID><ISSNLinking>1198-743X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000914">Antibodies, Viral</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000914" MajorTopicYN="N">Antibodies, Viral</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003140" MajorTopicYN="N">Communicable Disease Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004196" MajorTopicYN="Y">Disease Outbreaks</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017053" MajorTopicYN="N">Infection Control</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009426" MajorTopicYN="N" Type="Geographic">Netherlands</DescriptorName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011159" MajorTopicYN="Y">Population Surveillance</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011634" MajorTopicYN="N">Public Health</DescriptorName><QualifierName UI="Q000592" MajorTopicYN="Y">standards</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012015" MajorTopicYN="N">Reference Standards</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D040841" MajorTopicYN="N">Resource Allocation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName><QualifierName UI="Q000302" MajorTopicYN="N">isolation & purification</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012680" MajorTopicYN="N">Sensitivity and Specificity</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D045169" MajorTopicYN="N">Severe Acute Respiratory Syndrome</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="Y">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="Y">epidemiology</QualifierName><QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014944" MajorTopicYN="N">World Health Organization</DescriptorName></MeshHeading></MeshHeadingList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="pubmed"><Year>2006</Year><Month>11</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2008</Year><Month>8</Month><Day>16</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2006</Year><Month>11</Month><Day>24</Day><Hour>9</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">17121628</ArticleId><ArticleId IdType="pii">S1198-743X(14)62874-3</ArticleId><ArticleId IdType="doi">10.1111/j.1469-0691.2006.01552.x</ArticleId><ArticleId IdType="pmc">PMC7129494</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Science. 2003 Jun 20;300(5627):1966-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12766207</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Singapore Med J. 2005 Aug;46(8):414-20</Citation><ArticleIdList><ArticleId IdType="pubmed">16049612</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1995-2005</Citation><ArticleIdList><ArticleId IdType="pubmed">12671061</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2003 Jun 21;326(7403):1354-8</Citation><ArticleIdList><ArticleId IdType="pubmed">12816820</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Int J STD AIDS. 2005 Feb;16(2):91-4</Citation><ArticleIdList><ArticleId IdType="pubmed">15807934</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Nat Med. 2001 Jun;7(6):719-24</Citation><ArticleIdList><ArticleId IdType="pubmed">11385510</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Nov;10(11):1900-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15550198</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Med Virol. 2004 Jul;73(3):486-93</Citation><ArticleIdList><ArticleId IdType="pubmed">15170647</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Emerg Infect Dis. 2004 Sep;10(9):1653-6</Citation><ArticleIdList><ArticleId IdType="pubmed">15498170</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Apr 19;361(9366):1319-25</Citation><ArticleIdList><ArticleId IdType="pubmed">12711465</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>J Clin Microbiol. 2000 Nov;38(11):4096-101</Citation><ArticleIdList><ArticleId IdType="pubmed">11060074</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1977-85</Citation><ArticleIdList><ArticleId IdType="pubmed">12671062</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 Jul 26;362(9380):263-70</Citation><ArticleIdList><ArticleId IdType="pubmed">12892955</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>N Engl J Med. 2003 May 15;348(20):1986-94</Citation><ArticleIdList><ArticleId IdType="pubmed">12682352</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Lancet. 2003 May 24;361(9371):1767-72</Citation><ArticleIdList><ArticleId IdType="pubmed">12781535</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Epidemiol Rev. 1995;17(2):243-64</Citation><ArticleIdList><ArticleId IdType="pubmed">8654510</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Ann Intern Med. 2004 Sep 7;141(5):333-42</Citation><ArticleIdList><ArticleId IdType="pubmed">15326019</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Proc Biol Sci. 2003 Oct 7;270(1528):1979-89</Citation><ArticleIdList><ArticleId IdType="pubmed">14561285</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>Euro Surveill. 2005 Mar;10(3):39-43</Citation><ArticleIdList><ArticleId IdType="pubmed">15827372</ArticleId></ArticleIdList></Reference></ReferenceList><ReferenceList><Reference><Citation>BMJ. 2003 Sep 13;327(7415):620</Citation><ArticleIdList><ArticleId IdType="pubmed">12969941</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></pubmed></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/PubMed/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001F81 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd -nk 001F81 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= PubMed
|étape= Corpus
|type= RBID
|clé= pubmed:17121628
|texte= Public health implications of using various case definitions in The Netherlands during the worldwide SARS outbreak.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Corpus/RBID.i -Sk "pubmed:17121628" \
| HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |